non-peptidic helix mimetics based on a trimeric quinoline scaffold is described. The ability of these new compounds, as well as their synthetic dimeric intermediates, to bind to various members of the Bcl-2 protein anti-apoptotic group is also evaluated. The most interesting derivative of this new series (compound A) inhibited Bcl-xL/Bak, Bcl-xL/Bax and Bcl-xL/Bid interactions with IC50 values around
描述了基于三聚喹啉骨架的非肽螺旋模拟物的合成。还评估了这些新化合物及其合成的二聚体中间体与Bcl-2蛋白抗凋亡基团各个成员结合的能力。这个新系列最有趣的衍生物(化合物A)抑制Bcl-x L / Bak,Bcl-x L / Bax和Bcl-x L / Bid相互作用,IC 50值约为25μM。
TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS
申请人:Biswas Kaustav
公开号:US20130157996A1
公开(公告)日:2013-06-20
Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure:
where the definitions of the variables are provided herein.